Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied message and signaling that the study record cannot be viewed at the moment.
    Difference
    20%
    Check dated 2026-09-23T01:08:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.6.6 to v3.7.0, signaling a newer edition of the page content. This update is a metadata change that does not modify the study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:53:31.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.6) appears, replacing the previous v3.6.5. This signals an update to the page's metadata rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-09-01T19:01:18.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.5, replacing the previous v3.6.4. This reflects a small maintenance update to the site's revision history and does not change the study content.
    Difference
    0.0%
    Check dated 2026-08-11T17:51:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new page version. No study details or eligibility criteria are changed by this update.
    Difference
    0.0%
    Check dated 2026-07-28T12:15:37.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a minor update to the page template or underlying system.
    Difference
    0.0%
    Check dated 2026-07-07T02:40:48.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.